Hoth Therapeutics (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies for underserved medical needs, today announced the filing of two U.S. provisional patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback